Arsanis Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Arsanis Inc
TickerXFOR
CIK #0001501697
CUSIP98420X103
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address890 Winter Street, Suite 230, Waltham, MA 02451
Source [EDGAR]
CIK Filing 2011 - 2025
[0001501697] 10-K
[0001501697] 10-Q
[0001501697] 3
[0001501697] 4
[0001501697] 8-K
[0001501697] D
[0001501697] SC 13D
[0001501697] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Biotechnology Value Fund L P X4 Pharmaceuticals Inc [2025-08-20] 0.0
Deep Track Capital LP X4 Pharmaceuticals Inc [2025-08-19] 0.0
Trails Edge Capital Partners LP X4 Pharmaceuticals Inc [2025-08-18] 0.0
Coastlands Capital LP X4 Pharmaceuticals Inc [2025-08-18] 0.0
Bain Capital Life Sciences Fund LP X4 Pharmaceuticals Inc [2025-08-13] 0.0
BlackRock Inc X4 Pharmaceuticals Inc [2024-11-08] 6.7
BlackRock Inc X4 Pharmaceuticals Inc [2024-10-22] 6.7
Acorn BioVentures LP X4 Pharmaceuticals Inc [2024-02-14] 4.8
BlackRock Inc X4 Pharmaceuticals Inc [2024-01-31] 5.0
Millennium Management LLC X4 Pharmaceuticals Inc [2023-06-16] 5.2
Empery Asset Management LP X4 Pharmaceuticals Inc [2023-01-13] 5.12
Growth Equity Opportunities 18 VGE LLC X4 Pharmaceuticals Inc [2022-07-19] 0.9
Lincoln Park Capital Fund LLC X4 Pharmaceuticals Inc [2022-01-19] 6.44
Point72 Asset Management LP X4 Pharmaceuticals Inc [2021-11-17] 5.6
Hirschman Orin X4 Pharmaceuticals Inc [2021-06-29] 6.2
BlackRock Inc X4 Pharmaceuticals Inc [2021-02-02] 6.3
Ikarian Capital LLC X4 Pharmaceuticals Inc [2020-12-30] 5.1
RA Capital Management LP X4 Pharmaceuticals Inc [2020-02-14] 0.9
EcoR1 Capital LLC X4 Pharmaceuticals Inc [2019-12-17] 7.2
Bain Capital Life Sciences Fund LP X4 Pharmaceuticals Inc [2019-12-09] 9.99
FMR LLC X4 Pharmaceuticals Inc [2019-05-10] 0.0
Biotechnology Value Fund L P X4 Pharmaceuticals Inc [2019-04-23] 6.4
Cormorant Asset Management LP X4 Pharmaceuticals Inc [2019-04-22] 5.93
OrbiMed Advisors LLC X4 Pharmaceuticals Inc [2019-04-19] 0.8
Flynn James E X4 Pharmaceuticals Inc [2019-04-16] 6.69
Ragan Paula X4 Pharmaceuticals Inc [2019-03-22] 11.0
Bill & Melinda Gates Foundation X4 Pharmaceuticals Inc [2019-03-15] 1.8
X4 Pharmaceuticals Inc Arsanis Inc [2018-12-06] 48.2
SVLSF V LLC Arsanis Inc [2018-02-14] 6.5
Bill & Melinda Gates Foundation Arsanis Inc [2018-02-13] 5.1
FMR LLC Arsanis Inc [2017-12-11] 0.0
OrbiMed Advisors LLC Arsanis Inc [2017-11-30] 13.07
New Enterprise Associates 16 LP Arsanis Inc [2017-11-29] 14.6
Polaris Venture Partners V LP Arsanis Inc [2017-11-29] 13.2
Form 3/4/5 Filer 2011 - 2025
X4 Pharmaceuticals, Inc
Kirske David
Volpone John
Craig Adam R
Thoren Natasha Fay
McGirr David W J
Stewart Murray
de Craecker Francoise
Bridger Gary
Woods Keith
Wyzga Michael S
Baldry Mark
Arbet-Engels Christophe
Mostafa Adam S.
Ragan Paula
DiBiase Mary
Taveras Arthur
Aliski William
Lawton Alison Frances
Meisner Derek M
Cadavid Diego
Russo Rene
Skerlj Renato
Kelley Lynne E
Blech Isaac
Gray Michael
Behbahani Ali
Chang Carmen
Schulman Amy W
McGuire Terrance
Gerngross Tillman U.
Clark William D
Gordon Carl L
Nessi Claudio
Ross Michael Jay
Nagy Eszter
Stevens Anthony Chris
Mantus David
Makhzoumi Mohamad
Puttagunta Chetan
Sakoda Jon
Sandell Scott D
Sonsini Peter W.
Bill & Melinda Gates Foundation
Viswanathan Ravi
EMBL Technology Fund II GmbH & Co. KG
EMBL Ventures Verwaltungs GmbH
Muhlenbeck Frank
Adams Jan
Herr Stefan
NeoMed Management (Jersey) Ltd
NeoMed Innovation V L.P.
NeoMed Innovation V Ltd
GV 2016 GP LLC
GV 2016 GP LP
Alphabet Inc.
GV 2016 LP
Anna-Maria & Stephen Kellen Foundation, Inc.
Section 32 GP 1, LLC
Maris William J
Section 32 Fund 1, LP
SVLSF V LLC
SV Life Sciences Fund V Strategic Partners, L.P.
SV Life Sciences Fund VI, L.P.
SV Life Sciences Fund VI Strategic Partners, L.P.
SV Life Sciences Fund V LP
OrbiMed Advisors LLC
OrbiMed Capital GP IV LLC
Isaly Samuel D
Polaris Venture Partners Founders' Fund V, L.P.
Polaris Venture Management Co. V, L.L.C.
Flint Jonathan A
Polaris Venture Partners V, L.P.
Polaris Venture Partners Entrepreneurs' Fund V, L.P.
Polaris Venture Partners Special Founders' Fund V, L.P.
Alexandria Venture Investments, LLC
NEA Partners 16, L.P.
New Enterprise Associates 16, L.P.
NEA 16 GP LLC
Barris Peter J
Baskett Forest
Florence Anthony A. Jr.
Mott David M
SVLSF VI LLC
Form 13F Holdings
Firm Period DFND Voting Shares
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 563,859 563,859
NEA Management Company LLC [2025-06-30] DFND 499,559 499,559
Kingdon Capital Management LLC [2025-06-30] DFND 233,332 233,332
Vanguard Group Inc [2025-06-30] SOLE 0 230,627
BlackRock, Inc. [2025-06-30] SOLE 178,557 179,228
Susquehanna International Group LLP [2025-06-30] OTR 34,821 162,721
Acorn Capital Advisors LLC [2025-06-30] SOLE 153,730 153,730
GSA Capital Partners LLP [2025-06-30] SOLE 132,724 132,724
UBS Group AG [2025-06-30] DFND 109,927 109,959
Jane Street Group LLC [2025-06-30] DFND 97,344 97,344
Bank of America Corp /DE/ [2025-06-30] DFND 0 80,316
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM [2025-06-30] DFND 80,000 80,000
Millennium Management LLC [2025-06-30] SOLE 78,061 78,061
Pale Fire Capital SE [2025-06-30] DFND 0 60,051
Geode Capital Management LLC [2025-06-30] DFND 49,146 49,146
Squarepoint Ops LLC [2025-06-30] DFND 0 38,982
AQR Capital Management LLC [2025-06-30] DFND 26,240 26,240
Point72 Asset Management LP [2025-06-30] DFND 0 21,667
Goldman Sachs Group Inc [2025-06-30] DFND 18,864 18,864
Renaissance Technologies LLC [2025-06-30] SOLE 17,366 17,366
State Street Corp [2025-06-30] DFND 15,534 15,534
Virtu Financial LLC [2025-06-30] DFND 12,587 12,587
Schonfeld Strategic Advisors LLC [2025-06-30] SOLE 11,261 11,261
Morgan Stanley [2025-06-30] DFND 10,395 10,924
HRT Financial LP [2025-06-30] DFND 10,548 10,548
Russell Investments Group, Ltd. [2025-06-30] DFND 9,727 9,727
Tower Research Capital LLC (TRC) [2025-06-30] DFND 5,203 5,203
Group One Trading LLC [2025-06-30] SOLE 3,998 3,998
Royal Bank of Canada [2025-06-30] DFND 3,078 3,078
CWM LLC [2025-06-30] SOLE 0 2,414
Prev | Page 2 | Next
Terms | Privacy | Guide
tony@aum13f.com